IT1225462B - Sali organici di derivati della fisostigmina - Google Patents

Sali organici di derivati della fisostigmina

Info

Publication number
IT1225462B
IT1225462B IT8719964A IT1996487A IT1225462B IT 1225462 B IT1225462 B IT 1225462B IT 8719964 A IT8719964 A IT 8719964A IT 1996487 A IT1996487 A IT 1996487A IT 1225462 B IT1225462 B IT 1225462B
Authority
IT
Italy
Prior art keywords
derivatives
organic salts
physostigmin
organic
anion
Prior art date
Application number
IT8719964A
Other languages
English (en)
Other versions
IT8719964A0 (it
Inventor
Carlo Meroni
Stefano Maiorana
Mario Brufani
Massimo Pomponi
Riccardo Bernardi
Original Assignee
Mediolanum Farmaceutici Srl
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl, Consiglio Nazionale Ricerche filed Critical Mediolanum Farmaceutici Srl
Publication of IT8719964A0 publication Critical patent/IT8719964A0/it
Priority to IT8719964A priority Critical patent/IT1225462B/it
Priority to ES88104977T priority patent/ES2060616T3/es
Priority to EP88104977A priority patent/EP0298202B1/en
Priority to US07/172,799 priority patent/US4978673A/en
Priority to DE3851279T priority patent/DE3851279T2/de
Priority to AT88104977T priority patent/ATE110725T1/de
Priority to IE96088A priority patent/IE64617B1/en
Priority to CA000563027A priority patent/CA1331616C/en
Priority to KR1019880003709A priority patent/KR960007865B1/ko
Priority to JP63081443A priority patent/JPH0826023B2/ja
Application granted granted Critical
Publication of IT1225462B publication Critical patent/IT1225462B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
IT8719964A 1987-04-03 1987-04-03 Sali organici di derivati della fisostigmina IT1225462B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT8719964A IT1225462B (it) 1987-04-03 1987-04-03 Sali organici di derivati della fisostigmina
DE3851279T DE3851279T2 (de) 1987-04-03 1988-03-28 Organische Salze von Physostigminderivaten.
EP88104977A EP0298202B1 (en) 1987-04-03 1988-03-28 Organic salts of physostigmine derivatives
US07/172,799 US4978673A (en) 1987-04-03 1988-03-28 Organic salts of physostigmine derivatives
ES88104977T ES2060616T3 (es) 1987-04-03 1988-03-28 Sales organicas de derivados de fisostigmina.
AT88104977T ATE110725T1 (de) 1987-04-03 1988-03-28 Organische salze von physostigminderivaten.
IE96088A IE64617B1 (en) 1987-04-03 1988-03-30 Organic salts of physostigmine derivatives
CA000563027A CA1331616C (en) 1987-04-03 1988-03-31 Organic salts of physostigmine derivative
KR1019880003709A KR960007865B1 (ko) 1987-04-03 1988-04-02 피소스티그민 유도체의 유기염, 이의 제조방법 및 이를 포함하는 약제학적 조성물
JP63081443A JPH0826023B2 (ja) 1987-04-03 1988-04-04 フィソスチグミン誘導体の有機塩

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8719964A IT1225462B (it) 1987-04-03 1987-04-03 Sali organici di derivati della fisostigmina

Publications (2)

Publication Number Publication Date
IT8719964A0 IT8719964A0 (it) 1987-04-03
IT1225462B true IT1225462B (it) 1990-11-14

Family

ID=11162687

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8719964A IT1225462B (it) 1987-04-03 1987-04-03 Sali organici di derivati della fisostigmina

Country Status (10)

Country Link
US (1) US4978673A (it)
EP (1) EP0298202B1 (it)
JP (1) JPH0826023B2 (it)
KR (1) KR960007865B1 (it)
AT (1) ATE110725T1 (it)
CA (1) CA1331616C (it)
DE (1) DE3851279T2 (it)
ES (1) ES2060616T3 (it)
IE (1) IE64617B1 (it)
IT (1) IT1225462B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US5187165A (en) * 1987-05-15 1993-02-16 Hoechst-Roussel Pharmaceuticals Inc. Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US5177101A (en) * 1989-11-30 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
IT1244746B (it) * 1991-02-14 1994-08-08 Laboratorio Chimico Int Spa Procedimento per la preparazione dell'1,3a,8,-trimetil-1,2,3,3a,8,-8a-esaidro pirrol (2,3-b) indolo-5(3as,8ar)-eptilcarbammato
EP0513703A3 (en) * 1991-05-13 1993-01-13 Magis Farmaceutici S.P.A. Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle
IT1251166B (it) * 1991-08-09 1995-05-04 Chiesi Farma Spa Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono
US5171750A (en) * 1991-09-26 1992-12-15 The United States Of America As Represented By The Department Of Health And Human Services Substituted phenserines as specific inhibitors of acetylcholinesterase
US5206260A (en) * 1991-11-07 1993-04-27 Merck & Co., Inc. Hexahydropyrrolo[2,3-b]indole derivatives
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
PH30885A (en) * 1992-07-21 1997-12-23 Hoechst Roussel Pharma Preparation of physostigmie carbamate derivatives from physostigmine.
IT1276928B1 (it) * 1995-10-13 1997-11-03 Angelini Ricerche Spa Processo migliorato per produrre eptastigmina e nuovo intermedio utile allo scopo
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6495700B1 (en) * 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
JP2005350471A (ja) * 2004-06-08 2005-12-22 Axonyx Inc β−アミロイド前駆体タンパク質阻害剤およびＨＭＧＣｏＡ還元酵素阻害剤を使用するアルツハイマー病の進行を遅延させる方法
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
US20130096316A1 (en) * 2011-10-14 2013-04-18 Qr Pharma, Inc. Novel Method for Preparation of Bisnorcymerine and Salts Thereof
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
RS56949B1 (sr) 2012-12-13 2018-05-31 H Lundbeck As Kompozicije koje obuhvataju vortioksetin i donepezil
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
CN105142623A (zh) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 用于改善认知功能的方法和组合物
CN112843005B (zh) 2015-05-22 2023-02-21 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use

Also Published As

Publication number Publication date
EP0298202B1 (en) 1994-08-31
CA1331616C (en) 1994-08-23
IT8719964A0 (it) 1987-04-03
ES2060616T3 (es) 1994-12-01
JPS6425777A (en) 1989-01-27
DE3851279T2 (de) 1995-02-09
ATE110725T1 (de) 1994-09-15
KR880012602A (ko) 1988-11-28
JPH0826023B2 (ja) 1996-03-13
IE64617B1 (en) 1995-08-23
EP0298202A1 (en) 1989-01-11
IE880960L (en) 1988-10-03
US4978673A (en) 1990-12-18
DE3851279D1 (de) 1994-10-06
KR960007865B1 (ko) 1996-06-13

Similar Documents

Publication Publication Date Title
IT1225462B (it) Sali organici di derivati della fisostigmina
DK232989A (da) Antiviralt praeparat
ES2031865T3 (es) Un procedimiento para preparar derivados de imidas.
PT99134A (pt) Processo para a preparacao de derivados da piperazina
NO871990D0 (no) Quinolinkarboksylsyre-derivater.
FI875666A (fi) Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
DE3770724D1 (de) Thiazolidin-4-one-derivate un deren saeure-additionssalze.
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ATE84303T1 (de) Cysteinderivate.
IT1228537B (it) Derivati della cisteina ad azione espettorante
DE69119714T2 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
ES2041790T3 (es) Derivados de tetrahidroisoquinolina amino-substituidos y su procedimiento de obtencion.
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
PT99250A (pt) Processo para a preparacao de derivados de piperazina
DK656889A (da) Azabicykliske derivater
FI893505A (fi) Foerfarande foer framstaellning av substituerade quanyltioureaderivat.
DE3864029D1 (de) Cycloalkyl-substituierte 4-aminophenyl halo derivate und verfahren zur deren herstellung.
PT92355A (pt) Processo para a preparacao de derivados de di-hidro-piridina
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
DE69011174T2 (de) Catecholaminester.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950428